At the highest dose of 4.5 mg weekly, that number climbed to 47%
Treatment recommendations vary based on provider evaluation and individual goals
A: BPC-157 is not FDA-approved for human therapeutic use and is legally classified as a research compound
In this article, we will explore some of the various theories that are currently in circulation, which outline the cause as: Excessive production of porphyrin by skin bacteria stimulated by B12 A cobalt allergy Relative deficiency of vitamin B12 cofactors A detoxification reaction Vitamin B12 Acne The Work of Skin Bacteria
Using 1941 and 1987 city adress books and aerial photographs, it is possible to see the land uses, the industrial and commercial businesses of different historical eras
NHS protocols recommend B12 testing and appropriate treatment (oral supplements or intramuscular injections) for confirmed deficiency, not for weight loss purposes